RXR Rexinoids for Cancer Chemoprevention - Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents

Grant

Date/time Interval

  • September 1, 2017 - August 31, 2022
  • Total Award Amount

  • 497126.00
  • Direct Costs

  • 334765.00
  • Sponsor Award Id

  • P01CA210946
  • Contributor

  • Muccio Ph.D., Donald   Investigator  
  • Renfrow Ph.D., Matthew   Principal Investigator